Particle Therapy Market Analysis

ID: MRFR/MED/5535-HCR

85 Pages

Kinjoll Dey

October 2025

Particle Therapy Market Size, Growth and Trends Analysis by Type (Proton Therapy & Heavy Ion Therapy), Product & Service (Products & Others), Cancer Type (Prostate, Lung), System (Multi-Room & Single Room), Application (Treatment & Research) —  Forecast till 2035

Request Free Sample

Summary Table of Contents Segmentation Download PDF

Market Analysis

In-depth Analysis of Particle Therapy Market Industry Landscape

The global healthcare scene has seen the emergence of particle therapy, an advanced cancer treatment method that has altered how markets function within the Particle Therapy sector. Unlike traditional radiation therapies, which use X-rays, ionized particles such as protons or heavy ions are used by particle therapeutics to deliver doses to targeted cancer cells while minimizing harm to nearby healthy tissues in human bodies. An increase in global incidences forms one major dynamic behind growth in this sector, including but not limited to cancers, among other diseases related to old age, besides lifestyle issues contributing significantly toward it as well because when compared with other treatments, this enables precise exposure of cancer to radiation doses. Furthermore, technological advancements have significantly contributed to the current Particle Therapy market. With current developments in accelerator technology, beam delivery systems, and imaging techniques, particle therapy has become more precise and efficient. As the Particle Therapy industry grows, collaboration and partnerships among major healthcare stakeholders have visibly shaped its dynamics. Major medical equipment manufacturers, pharmaceutical companies, and research institutions are collaborating to develop and market particle therapy solutions. These alliances aim to pool resources together so as to share knowledge and hasten the development of new technologies, hence cultivating an atmosphere that is more competitive and innovative. The evolving regulatory landscape is another influential factor shaping the market dynamics of particle therapy. Regulatory agencies around the world are recognizing the importance of particle therapy by putting in place guidelines and standards for its safety implementation. This regulatory support will not only increase investor confidence but also attract healthcare facilities to integrate particle therapy into their treatment portfolios, thereby supporting further market growth. Despite having many advantages, there are still challenges within this area, a good example being the high initial costs associated with establishing particle therapy centers. The set-up cost for acquiring infrastructure, equipment, and training on how to use these machines makes it very expensive.

Market Highlights

Author

Kinjoll Dey

Research Analyst Level I

He is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Kinjoll is comfortably versed in data centric research backed by healthcare educational background. He leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. His key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.

Get In Touch

FAQs

What is the latest valuation of the particle therapy market?

The latest valuation of the particle therapy market in 2032 was USD 2.40 Billion.

What is the projected CAGR for the particle therapy market during the forecast period of 2024 to 2032?

The forecasted CAGR for the particle therapy market is 9.89% for the duration of 2024 to 2032.

What would be the driving factors for the particle therapy market?

The particle therapy market would be driven by factors like rising cases of cancer, an increasing number of particle therapy center, low risk of treatment, and potential retreatment opportunity can trigger better market growth.

Which application segment would lead the global particle therapy market?

The pediatric cancer segment has the opportunity to register the highest growth in the particle therapy market.

Which region has the upper hand in the particle therapy market?

The Americas has the setup to continue their domination of the particle therapy market.

1. Market Overview

2. Market Trends

3. Market Segment Insights

4. Key Players and Competitive Insights

5. Industry Developments

6. Market Segmentation

7. Report Scope

8. Market Highlights

9. FAQs

Customize Report

Certified Researchers

Market Summary

The Global Particle Therapy Market is projected to grow from 1.7 USD Billion in 2024 to 3.18 USD Billion by 2035.

Key Market Trends & Highlights

Global Particle Therapy Market Key Trends and Highlights

The market is expected to experience a compound annual growth rate (CAGR) of 5.87% from 2025 to 2035.
By 2035, the market valuation is anticipated to reach 3.18 USD Billion, reflecting robust growth.
In 2024, the market is valued at 1.7 USD Billion, indicating a strong foundation for future expansion.
Growing adoption of particle therapy due to its precision in targeting tumors is a major market driver.

Particle Therapy Market

CAGR

5.87%

Market Size & Forecast

2024 Market Size	1.7 (USD Billion)
2035 Market Size	3.18 (USD Billion)
CAGR (2025-2035)	5.87%
Largest Regional Market Share in 2024	latin_america)

Major Players

Advanced Oncotherapy PLC, Danfysik A/S, Hitachi, Ltd., Ion Beam Applications Sa (IBA), Mevion Medical Systems, Inc., Optivus Proton Therapy, Inc., Protom International, Inc., Provision Healthcare, LLC, Sumitomo Heavy Industries, Ltd., Varian Medical Systems, Inc.

Market Trends

Particle Therapy Market Market Drivers

Technological Advancements

Technological innovations play a pivotal role in the Global Particle Therapy Market Industry. The development of advanced particle accelerators and imaging technologies enhances the efficacy and safety of treatments. Innovations such as real-time imaging and adaptive therapy allow for personalized treatment plans, improving patient outcomes. As technology continues to evolve, the cost of particle therapy systems is expected to decrease, making them more accessible. This trend is likely to attract more healthcare facilities to invest in particle therapy, contributing to the market's growth. By 2035, the market could potentially reach 3.18 USD Billion, driven by these advancements.

Increasing Cancer Incidence

The Global Particle Therapy Market Industry is significantly driven by the rising incidence of cancer worldwide. As per recent statistics, cancer cases are projected to increase, necessitating advanced treatment modalities. Particle therapy, particularly proton therapy, offers targeted treatment with minimal damage to surrounding healthy tissues. This precision is crucial for treating complex tumors, which are becoming more prevalent. The market is expected to reach 1.7 USD Billion in 2024, reflecting the growing demand for innovative cancer treatments. The increasing awareness among patients and healthcare providers about the benefits of particle therapy further propels market growth.

Expansion of Treatment Centers

The expansion of treatment centers offering particle therapy is a significant driver of the Global Particle Therapy Market Industry. As more hospitals and specialized cancer treatment centers incorporate particle therapy into their treatment offerings, patient access to these advanced therapies increases. This expansion is often supported by partnerships between healthcare institutions and technology providers, facilitating the establishment of new facilities equipped with state-of-the-art particle therapy systems. The growing number of treatment centers not only enhances patient access but also fosters competition, potentially leading to improved treatment options and reduced costs. This trend is expected to contribute to the overall market growth.

Growing Awareness and Acceptance

The growing awareness and acceptance of particle therapy among patients and healthcare professionals are crucial drivers of the Global Particle Therapy Market Industry. Educational campaigns and clinical trial results highlighting the effectiveness of particle therapy in treating various cancers have led to increased patient demand. As more patients seek out advanced treatment options, healthcare providers are more inclined to offer particle therapy services. This trend is further supported by patient advocacy groups that promote awareness of innovative cancer treatments. Consequently, the market is poised for growth as acceptance of particle therapy continues to rise.

Government Initiatives and Funding

Government initiatives and funding significantly influence the Global Particle Therapy Market Industry. Various countries are recognizing the importance of advanced cancer treatment options and are investing in research and infrastructure for particle therapy. For instance, several governments have launched programs to subsidize the costs of particle therapy equipment and treatment, making it more accessible to patients. This support not only enhances the availability of particle therapy but also encourages healthcare providers to adopt these technologies. As a result, the market is likely to experience robust growth, with a projected CAGR of 5.87% from 2025 to 2035.

Market Segment Insights

Particle Therapy Market Segment Insights

The Global Particle Therapy Market has been segmented on the basis of type, product & service, cancer type, system, and application.

Particle Therapy Market Type Insights

On the basis of type, the market has been classified as proton therapy and heavy ion therapy.

Particle Therapy Market Product and Services Insights

The market, by product and services, has been segmented into products and services. Products are further segmented into cyclotrons, synchrotrons, and synchrocyclotrons.

Particle Therapy Market Cancer Type Insights

Based on cancer type, the market has been segmented into prostate cancer, lung cancer, pediatric cancer, head and neck cancer, breast cancer, and others.

Particle Therapy Market System Insights

The market, by system, has been segmented into multi-room systems and single-room systems.

Particle Therapy Market Application Insights

On the basis of application, the market has been classified as treatment applications and research applications. The pediatric cancer segment is expected to hold the largest market share of the particle therapy market, by cancer type, during the forecast period. Also, research applications to register the highest CAGR in the global market during the forecast period.

Get more detailed insights about Particle Therapy Market Research Report – Global Forecast till 2035

Regional Insights

Key Companies in the Particle Therapy Market market include

Industry Developments

In July 2023, Hitachi, Ltd. delivered a proton therapy system to the HKSH Medical Group ("HKSH"), which includes Hong Kong Sanatorium and Hospital. The system has begun treatment, signaling the start of proton therapy treatment services in Hong Kong.

In May 2022, Mevion Medical Systems has been selected to install a MEVION S250i Proton Therapy System with HYPERSCAN Pencil Beam Scanning (PBS) in a comprehensive hospital in Southern China.

In April 2022, The Connecticut Office of Health Strategy (OHS) approved with conditions, the certificate of need application to allow Harford HealthCare Corporation and Yale New Haven Health Services Corporation to establish proton therapy services through a newly established joint venture, Connecticut Proton Therapy Center, LLC.

In December 2021, Moffitt announced proton therapy treatment facility as part of its ongoing expansion and will allow radiation oncologists to treat cancer with precisely directed doses of radiation, which protects healthy tissue.

in September 2021, ProTom International entered into an agreement with the Behnke Group. The relationship would enhance ProTom's expansion of United States markets through connections with the Behnke Group's network in the industry, allowing a greater number of cancer patients to benefit from ProTom's world-class proton therapy treatments. Also, in April 2020, Mevion Medical Systems received a medical device license from Health Canada for MEVION S250i Proton Therapy System with HYPERSCAN Pencil Beam Scanning (PBS).

A comprehensive hospital in Southern China has been awarded to install a MEVION S250i Proton Therapy System with HYPERSCAN Pencil Beam Scanning (PBS) by Mevion Medical Systems scheduled for completion in May 2022.

Moreover, The Connecticut Office of Health Strategy (OHS) approved, with conditions, the certificate of need application to allow Harford HealthCare Corporation and Yale New Haven Health Services Corporation to establish proton therapy services through a newly established joint venture, Connecticut Proton Therapy Center, LLC in April 2022.

In addition to that, IBA Worldwide announced a collaboration agreement with Tractebel in April 2021. This will fill the niche of proton therapy design and construction projects for IBA’s clients.

For example, Moffitt Cancer Center announced its plans for a new proton therapy treatment facility in December 2021 that will offer precise radiation doses while sparing healthy tissues from damage.

Thus, Behnke Group was contracted by ProTom International in September 2021. To expand into the United States market, this association would increase the number of referrals made to ProTom from cancer patients who would be better served by having access to their best-in-class proton therapies through industry-leading contacts held by Behnke Group.

Hitachi Ltd. also revealed plans for an advanced proton therapy system at Clinica Universidad de Navarra in Spain in May 2020. It is powered using spot scanning technology that dispatches protons straight into tumors.

Also worth noting is that in April 2020, Mevion Medical Systems was awarded a medical device license from Health Canada for MEVION S250i Proton Therapy System with HYPERSCAN Pencil Beam Scanning (PBS).

Advanced Oncotherapy plc stated in December 2017 that it has secured new finance of USD 46.75 million, with USD 37.5 million coming from a new Chinese investor. During the assessment period, the lack of an acceptable reimbursement mechanism and the significant expenditures associated with the development of these centers may stifle particle therapy market expansion. In 2017, Mitsubishi Electric agreed to sell its particle therapy systems business to Hitachi and merge the two companies into one. Hitachi was able to strengthen its position in the proton therapy business as a result of this. The first compact proton therapy system in the Middle East was developed by Royal Philips (US) and Proton Partners International (UK) in collaboration with IBA (Belgium). Intended Audience:

Medical devices manufacturers

Medical devices product distributors and suppliers

Healthcare providers

Research institutes and academic centers

Contract manufacturing organizations

Government associations

Market research and consulting

Future Outlook

Particle Therapy Market Future Outlook

The Global Particle Therapy Market is projected to grow at a 5.87% CAGR from 2024 to 2035, driven by technological advancements, increasing cancer prevalence, and rising healthcare expenditure.

New opportunities lie in:

Develop advanced particle therapy systems to enhance treatment precision and patient outcomes.
Expand partnerships with healthcare providers to increase access to particle therapy services.
Invest in research for innovative applications of particle therapy in non-oncological conditions.

By 2035, the Global Particle Therapy Market is expected to achieve substantial growth, solidifying its role in cancer treatment.

Market Segmentation

Particle Therapy Type Outlook

Proton Therapy
Heavy Ion Therapy

Particle Therapy System Outlook

Multi-Room Systems
Single-Room Systems

Particle Therapy Application Outlook

Treatment Applications
Research Applications

Particle Therapy Cancer Type Outlook

Prostate Cancer
Lung Cancer
Pediatric Cancer
Head and Neck Cancer
Breast Cancer
Others

Particle Therapy Product & Service Outlook

Products
Cyclotrons
Synchrotrons
Synchrocyclotrons
Services

Report Scope

Report Attribute/Metric	Details
Market Size	USD 2.40 Billion By 2032
CAGR	9.89%
Base Year	2023
Forecast Period	2024-2032
Historical Data	2022
Forecast Units	Value (USD Billion)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered	Type, Product & Service, Cancer Type, System, and Application
Geographies Covered	North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Key Vendors	Advanced Oncotherapy PLC., Danfysik A/S, Hitachi, Ltd., Ion Beam Applications Sa (IBA), Mevion Medical Systems, Inc., Optivus Proton Therapy, Inc., Protom International, Inc., Provision Healthcare, LLC, Sumitomo Heavy Industries, Ltd., Varian Medical Systems, Inc.
Key Market Opportunities	Increased R&D spending and new product releases
Key Market Drivers	Rising prevalence of cancer, low risk of treatment-induced illnesses and low radiation dose treatment